“With this Fund we plan to accelerate our collaborations with leading life sciences entrepreneurs, strategic companies, research institutions and physicians, to drive the creation of novel therapies that address unmet medical needs,” commented Jonathan Silverstein in the same release, also an OrbiMed Partner and Co-Head of Global Private Equity.
I hope that means their existing collaboration in Unilfe gets a big boost
